Employee Stock Option Fund Investor
The ESO Fund provides funding for employees of venture-backed companies to absorb the financial risk of exercising stock options.
Technology:
Cell_Therapies
Industry:
AI
Headquarters:
San Mateo, California, United States
Founded Date:
2012-08-01
Employees Number:
11-50
Investor Type:
Secondary Purchaser
Investment Stage:
Debt, Early Stage Venture, Late Stage Venture, Post-Ipo, Secondary Market
Number Of Exits:
114
Estimated Revenue:
$50M to $100M
Register and Claim Ownership